Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a new revision label 'Revision: v3.3.2' in the history and removed the previous label 'Revision: v3.3.1'. This is a minor system update.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page history lists a new Revision: v3.3.1 and the removal of Revision: v3.2.0 in the version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedRemoval of the government funding notice banner from the page header; the core study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check44 days agoChange DetectedVersion 13 (2025-06-13) was added, showing updates to the Study Status and Recruitment Status in the record history.SummaryDifference0.1%

- Check73 days agoChange DetectedUpgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.SummaryDifference12%

- Check80 days agoChange Detected- Version updated from v3.0.2 to v3.1.0. This indicates a new release/build; no other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.